Heat-killed VSL#3 Ameliorates Dextran Sulfate Sodium (DSS)-Induced Acute Experimental Colitis in Rats
Open Access
- 19 December 2013
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 15 (1), 15-28
- https://doi.org/10.3390/ijms15010015
Abstract
To determine the effects of heat-killed VSL#3 (B. breve, B. longum and B. infantis; L. plantarum, L. bulgaricus, L. casei and L. acidophilus; S. salivarius subsp. thermophilus) therapy in the dextran sulfate sodium (DSS)-induced acute experimental colitis in rats. Acute experimental colitis was induced in rats by 5% DSS and freely drink for seven days. Beginning on Day 8, rats underwent gavage once daily for seven days with heat-killed probiotic VSL#3 (0.6 g/kg/day), colonic damage was evaluated histologically and biochemically seven days after gavage. Expression of inflammatory related mediators (STAT3, P-STAT3) and cytokines (IL-6, IL-23, TGFβ) in colonic tissue were detected. The results revealed that heat-killed and live VSL#3 have identical anti-inflammatory properties by the assessed DAI (disease activity index), colon length, histological tissue and MPO activity. Heat-killed and live VSL#3 results in reduced IL-6, IL-23, TGFβ, STAT3 and P-STAT3 expression in colonic tissue. Heat-killed and live VSL#3 have showed the similar anti-inflammatory activity by inhibiting IL-6/STAT3 pathway in the DSS-induced acute experimental colitis in rats.This publication has 44 references indexed in Scilit:
- VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164b therapyJournal of Translational Medicine, 2013
- Heat-killed body of lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier functionInflammatory Bowel Diseases, 2011
- Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal IntegrityPLOS ONE, 2007
- Chemically induced mouse models of intestinal inflammationNature Protocols, 2007
- The PPARγ Agonist Rosiglitazone Impairs Colonic Inflammation in Mice with Experimental ColitisJournal of Clinical Immunology, 2007
- IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6JCI Insight, 2006
- INTERLEUKIN-6: From Basic Science to Medicine—40 Years in ImmunologyAnnual Review of Immunology, 2005
- CD4+CD25+ Regulatory T Cells Can Mediate Suppressor Function in the Absence of Transforming Growth Factor β1 Production and ResponsivenessThe Journal of Experimental Medicine, 2002
- The Immunology of Mucosal Models of InflammationAnnual Review of Immunology, 2002
- Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel diseaseDigestive Diseases and Sciences, 1992